EhmetDX

About:

EhmetDX is commercializing the latest advancements in medical device technology to address identifiable needs within the healthcare market.

Website: http://ehmetdx.com/

Top Investors: Third Seven Capital

Description:

EhmetDX is commercializing the latest advancements in medical device technology to address identifiable needs within the healthcare market. The company's patented technology allows the practitioner to deliver whole or partial breast irradiation while minimizing exposure to critical structures at risks such as lung, heart, and skin, and lowering the whole-body dose to the patient. By offering these advantages, clinicians can apply novel approaches such as accelerated radiation treatment to reduce procedure time as well as allowing for advanced techniques such as stereotactic radiation therapy.

Total Funding Amount:

$510000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Plymouth, Michigan, United States

Founded Date:

2015-01-01

Founders:

Michael Teicher, Neal Clinthorne

Number of Employees:

251-500

Last Funding Date:

2018-12-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai